Monsenso expands to Israel as part of a real-world evidence project in pharma

Monsenso is translating its digital health app to Hebrew and Russian as part of a real-world evidence project with a pharmaceutical customer in Israel.

Monsenso’s digital health solution is translated to Hebrew and Russian and will be implemented in Israel as part of a project, where it will be used to collect real-world patient-reported health data and data from connected wearables to support evidence generation for a specific drug.

With these recent additions, Monsenso’s digital health solution is now available in 19 countries and 12 languages.

The project is a great example of the relevance of Monsenso’s solution to help pharmaceuticals generate the evidence necessary to support regulatory approval and reimbursement dialogues. It helps pave the way to provide Monsenso’s solution internationally to customers wishing to collect valuable, longitudinal patient data via daily self-reports, periodic clinical questionnaires as well as sensor data from phones and connected wearables to support studies and clinical practice.

CEO Thomas Lethenborg says: “We are excited to continue our success in the pharmaceutical market and offer our digital health solution in more languages and countries going forward, thus enabling even more individuals globally to better take care of their mental health”.

About Monsenso
Monsenso is an innovative technology company offering a digital health solution used for decentralised trials, remote patient monitoring and treatment support. Our mission is to contribute to improved health for more people at lower costs by supporting treatment digitally and leveraging patient-reported outcomes data. Our solution helps optimise the treatment and gives a detailed overview of an individual’s health through the collection of outcome, adherence, and behavioural data. It connects individuals, carers, and health care providers to enable personalised treatment, remote care, and early intervention. We collaborate with health and social care, pharmaceuticals, and leading researcher worldwide in our endeavours to deliver solutions that fit into the life of patients and health care professionals. To learn more visit